Cash flow LINTEC Corporation

Stocks

7966

JP3977200009

Specialty Chemicals

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-07-10 am EDT			5-day change	1st Jan Change
6,560.00 ^JPY	+0.61%		-10.26%	+48.42%

May. 21	Lintec Corporation Establishes Lintec Tsukuba Innovative Creation Center	CI
May. 08	LINTEC Corporation Reports Earnings Results for the Full Year Ended March 31, 2026	CI

7ae039f52cbb968b1a185f240973371.3j_o93RuTOuWfmpAfDWhgkHFi9MlIM_v3yXJOZwkqgM.6gmLlT0fIYP8ORADPwf7yni1_rRoeJjdqVybAd5F7ECkd6eUIw0BkfcHCQ

Published financial data: LINTEC CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	257B	285B	276B	316B	319B
Total Revenues	257B	285B	276B	316B	319B
Cost of Goods Sold, Total	192B	221B	215B	236B	238B
Gross Profit	65.14B	63.18B	61.41B	79.84B	81.46B
Selling General & Admin Expenses, Total	33.89B	38.22B	39.56B	42.81B	42.36B
Provision for Bad Debts	6M	21M	8M	-23M	176M
R&D Expenses	7.88B	9.07B	9.04B	10.06B	11.29B
Depreciation & Amortization - (IS)	1.78B	2.07B	2.18B	2.43B	2.48B
Other Operating Expenses, Total	43.55B	49.38B	50.78B	55.28B	56.31B
Operating Income	21.58B	13.8B	10.63B	24.56B	25.16B
Interest Expense, Total	-110M	-116M	-398M	-305M	-325M
Interest And Investment Income	417M	403M	650M	1.02B	754M
Net Interest Expenses	307M	287M	252M	711M	429M
Currency Exchange Gains (Loss)	1B	1.43B	692M	617M	428M
Other Non Operating Income (Expenses)	195M	406M	224M	356M	115M
EBT, Excl. Unusual Items	23.09B	15.92B	11.8B	26.25B	26.13B
Gain (Loss) On Sale Of Investments	531M	620M	-11M	316M	-118M
Gain (Loss) On Sale Of Assets	-392M	-334M	-233M	-83M	-465M
Asset Writedown	-	-347M	-1.02B	-7.73B	-879M
Other Unusual Items	1M	-1M	-1.09B	2M	-196M
EBT, Incl. Unusual Items	23.23B	15.86B	9.45B	18.75B	24.47B
Income Tax Expense	6.55B	4.36B	4.19B	4.26B	7.09B
Earnings From Continuing Operations	16.68B	11.5B	5.26B	14.49B	17.38B
Net Income to Company	16.68B	11.5B	5.26B	14.49B	17.38B
Minority Interest	-41M	11M	-18M	-17M	-4M
Net Income - (IS)	16.64B	11.51B	5.24B	14.48B	17.37B
Net Income to Common Incl Extra Items	16.64B	11.51B	5.24B	14.48B	17.37B
Net Income to Common Excl. Extra Items	16.64B	11.51B	5.24B	14.48B	17.37B
Per Share Items
Net EPS - Basic	232.12	167.84	76.66	211.98	264.48
Basic EPS - Continuing Operations	232.12	167.84	76.66	211.98	264.48
Basic Weighted Average Shares Outstanding	71.69M	68.59M	68.4M	68.29M	65.69M
Net EPS - Diluted	231.96	167.74	76.63	211.89	264.38
Diluted EPS - Continuing Operations	231.96	167.74	76.63	211.89	264.38
Diluted Weighted Average Shares Outstanding	71.74M	68.64M	68.43M	68.32M	65.72M
Normalized Basic EPS	200.72	145.26	107.54	239.95	248.54
Normalized Diluted EPS	200.58	145.17	107.49	239.85	248.44
Dividend Per Share	88	88	88	100	110
Payout Ratio	33.9	55.82	114.76	44.4	40.11
Supplemental Items
EBITDA	34.68B	28.69B	26.53B	41.92B	42.34B
EBITA	24.78B	17.54B	14.69B	29.1B	29.62B
EBIT	21.58B	13.8B	10.63B	24.56B	25.16B
Effective Tax Rate - (Ratio)	28.18	27.49	44.33	22.72	28.99
Normalized Net Income	14.39B	9.96B	7.36B	16.39B	16.33B
Non-Cash Pension Expense	67M	180M	-137M	-509M	-281M
Supplemental Operating Expense Items
Selling and Marketing Expenses	5.97B	5.82B	5.24B	5.77B	5.76B
Research And Development Expense From Footnotes	7.88B	9.07B	9.04B	10.06B	11.29B

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	55.42B	38.03B	55.49B	55.51B	60.27B
Total Cash And Short Term Investments	55.42B	38.03B	55.49B	55.51B	60.27B
Accounts Receivable, Total	62.29B	58.65B	64.58B	64.54B	69.17B
Total Receivables	62.29B	58.65B	64.58B	64.54B	69.17B
Inventory	52.54B	67.25B	59.55B	64.05B	58.68B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	11.79B	8.01B	8.36B	8.67B	7.96B
Total Current Assets	182B	172B	188B	193B	196B
Net Property Plant And Equipment	90.22B	102B	114B	117B	118B
Long-term Investments	4.09B	8.49B	8.42B	7.4B	12.41B
Goodwill	16.96B	15.01B	15.06B	11.77B	7.09B
Other Intangibles, Total	1.86B	2.7B	3.24B	3.16B	2.94B
Deferred Tax Assets Long-Term	7.4B	5.15B	4.82B	8.44B	6.7B
Other Long-Term Assets, Total	1M	1M	2M	2M	1M
Total Assets	303B	305B	334B	340B	343B
Liabilities
Accounts Payable, Total	44.28B	36.98B	45.7B	40.35B	37.27B
Accrued Expenses, Total	2.71B	2.58B	2.45B	2.79B	2.88B
Short-term Borrowings	1.29B	960M	1.4B	1.3B	700M
Current Portion of Long-Term Debt	1.35B	1.6B	1.97B	1.84B	2.22B
Current Income Taxes Payable	4.21B	1.29B	1.98B	5B	3.8B
Other Current Liabilities	18.47B	16.42B	22.42B	18.71B	19.09B
Total Current Liabilities	72.31B	59.82B	75.92B	69.99B	65.97B
Long-Term Debt	1.47B	-	5.89B	3.79B	1.9B
Long-Term Leases	-	-	-	3.41B	2.69B
Pension & Other Post Retirement Benefits	15.94B	12.93B	13.67B	14.67B	12.57B
Other Non Current Liabilities	3.1B	4.98B	5.19B	2.48B	1.35B
Total Liabilities	92.81B	77.73B	101B	94.35B	84.49B
Common Stock, Total	23.32B	23.36B	23.36B	23.36B	23.36B
Additional Paid In Capital	26.94B	26.71B	26.7B	26.63B	26.64B
Retained Earnings	166B	171B	171B	170B	180B
Treasury Stock	-14.12B	-17.66B	-17.57B	-11.7B	-16.82B
Comprehensive Income and Other	6.92B	22.71B	29B	37.12B	43.92B
Total Common Equity	209B	226B	232B	245B	257B
Minority Interest	451M	715M	703M	758M	759M
Total Equity	210B	227B	233B	246B	258B
Total Liabilities And Equity	303B	305B	334B	340B	343B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	68.99M	68.39M	68.42M	65.93M	65.5M
ECS Total Common Shares Outstanding	69.83M	68.36M	68.4M	67.35M	65.48M
Book Value / Share	3K	3.31K	3.4K	3.64K	3.93K
Tangible Book Value	190B	209B	214B	230B	247B
Tangible Book Value Per Share	2.73K	3.05K	3.13K	3.42K	3.78K
Total Debt	4.11B	2.56B	9.26B	10.34B	7.52B
Net Debt	-51.31B	-35.47B	-46.23B	-45.17B	-52.75B
Debt Equivalent of Unfunded Proj. Benefit Obligation	15.94B	9.16B	10.07B	11.66B	3.85B
Minority Interest, Total (Incl. Fin. Div)	451M	715M	703M	758M	759M
Inventories - Raw Materials, Total	15.56B	21.11B	15.14B	17.63B	16.16B
Inventories - Work In Process, Total	17.76B	23.81B	26.04B	25.43B	23.77B
Inventories - Finished Goods, Total	19.21B	22.33B	18.36B	20.99B	18.74B
Inventories - Others	1M	-	-	1M	1M
Full Time Employees	5.16K	5.42K	5.48K	5.31K	5.24K
Accumulated Allowance for Doubtful Accounts (Supple)	62M	155M	181M	166M	313M

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	23.23B	15.86B	9.45B	18.75B	24.47B
Depreciation & Amortization - CF	9.9B	11.14B	11.84B	12.82B	12.72B
Amortization of Goodwill and Intangible Assets - (CF)	3.2B	3.74B	4.06B	4.54B	4.46B
Depreciation & Amortization, Total	13.1B	14.89B	15.9B	17.36B	17.18B
(Gain) Loss From Sale Of Asset	197M	470M	1.1B	7.62B	1.13B
(Gain) Loss on Sale of Investments - (CF)	-249M	-621M	5M	-261M	-482M
Other Operating Activities, Total	-6.53B	-7.52B	-3.35B	-4.71B	-9B
Change In Accounts Receivable	6.18B	5.61B	-3.13B	1.95B	-4.06B
Change In Inventories	-8.55B	-11.75B	10.92B	-1.95B	5.13B
Change In Accounts Payable	-3.78B	-9.98B	6.24B	-5.9B	-2.84B
Change in Other Net Operating Assets	1.04B	-1.02B	2.07B	835M	1.92B
Cash from Operations	24.64B	5.94B	39.2B	33.72B	33.45B
Capital Expenditure	-8.52B	-12.55B	-14.43B	-23.76B	-14.69B
Sale of Property, Plant, and Equipment	17M	79M	108M	436M	12M
Cash Acquisitions	-6.35B	-	-1.09B	-	-
Divestitures	478M	586M	22M	-	-
Sale (Purchase) of Intangible assets	-210M	-1.18B	-497M	-385M	-542M
Investment in Marketable and Equity Securities, Total	-385M	979M	1.33B	-1.01B	584M
Net (Increase) Decrease in Loans Originated / Sold - Investing	7M	-16M	-5M	-10M	-6M
Other Investing Activities, Total	-4.68B	-38M	-6.95B	61M	52M
Cash from Investing	-19.64B	-12.14B	-21.51B	-24.67B	-14.59B
Short Term Debt Issued, Total	-	-	485M	-	-
Long-Term Debt Issued, Total	-	-	6.8B	-	-
Total Debt Issued	-	-	7.28B	-	-
Short Term Debt Repaid, Total	-331M	-462M	-	-100M	-600M
Long-Term Debt Repaid, Total	-1.23B	-1.47B	-1.72B	-1.77B	-1.87B
Total Debt Repaid	-1.56B	-1.93B	-1.72B	-1.87B	-2.47B
Repurchase of Common Stock	-6.54B	-3.56B	-1M	-3.09B	-5.24B
Common Dividends Paid	-5.64B	-6.43B	-6.02B	-6.43B	-6.97B
Common & Preferred Stock Dividends Paid	-5.64B	-6.43B	-6.02B	-6.43B	-6.97B
Other Financing Activities, Total	-714M	-864M	-829M	-938M	-914M
Cash from Financing	-14.46B	-12.78B	-1.29B	-12.33B	-15.6B
Foreign Exchange Rate Adjustments	2.42B	2.23B	1.95B	1.59B	1.28B
Miscellaneous Cash Flow Adjustments	-	-	179M	-	-1M
Net Change in Cash	-7.03B	-16.75B	18.54B	-1.69B	4.55B
Supplemental Items
Cash Interest Paid	118M	122M	300M	333M	349M
Cash Income Tax Paid (Refund)	6.54B	7.58B	3.5B	4.66B	9.14B
Levered Free Cash Flow	8.34B	-9.98B	24.07B	-2.08B	15.11B
Unlevered Free Cash Flow	8.41B	-9.91B	24.32B	-1.89B	15.31B
Change In Net Working Capital	9.44B	19.7B	-16.7B	10.46B	2.36B
Net Debt Issued / Repaid	-1.56B	-1.93B	5.56B	-1.87B	-2.47B

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	4.63	2.84	2.08	4.55	4.6
Return on Total Capital	6.48	3.89	2.82	6.16	6.02
Return On Equity %	8.2	5.26	2.29	6.05	6.89
Return on Common Equity	8.19	5.28	2.29	6.06	6.91
Margin Analysis
Gross Profit Margin %	25.36	22.2	22.22	25.27	25.51
SG&A Margin	13.19	13.43	14.32	13.55	13.26
EBITDA Margin %	13.5	10.08	9.6	13.27	13.26
EBITA Margin %	9.65	6.16	5.32	9.21	9.27
EBIT Margin %	8.4	4.85	3.85	7.77	7.88
Income From Continuing Operations Margin %	6.5	4.04	1.9	4.59	5.44
Net Income Margin %	6.48	4.04	1.9	4.58	5.44
Net Avail. For Common Margin %	6.48	4.04	1.9	4.58	5.44
Normalized Net Income Margin	5.6	3.5	2.66	5.19	5.11
Levered Free Cash Flow Margin	3.25	-3.51	8.71	-0.66	4.73
Unlevered Free Cash Flow Margin	3.27	-3.48	8.8	-0.6	4.79
Asset Turnover
Asset Turnover	0.88	0.94	0.87	0.94	0.93
Fixed Assets Turnover	3.02	2.97	2.56	2.74	2.72
Receivables Turnover (Average Receivables)	4.05	4.71	4.48	4.89	4.78
Inventory Turnover (Average Inventory)	4.21	3.7	3.39	3.82	3.88
Short Term Liquidity
Current Ratio	2.52	2.87	2.48	2.75	2.97
Quick Ratio	1.63	1.62	1.58	1.72	1.96
Operating Cash Flow to Current Liabilities	0.34	0.1	0.52	0.48	0.51
Days Sales Outstanding (Average Receivables)	90.16	77.55	81.61	74.57	76.4
Days Outstanding Inventory (Average Inventory)	86.6	98.73	107.97	95.53	94.14
Average Days Payable Outstanding	79.03	62.8	73.02	65.26	60.91
Cash Conversion Cycle (Average Days)	97.73	113.47	116.56	104.84	109.63
Long Term Solvency
Total Debt/Equity	1.96	1.13	3.98	4.2	2.91
Total Debt / Total Capital	1.92	1.12	3.82	4.03	2.83
LT Debt/Equity	0.7	-	2.53	2.93	1.78
Long-Term Debt / Total Capital	0.69	-	2.43	2.81	1.73
Total Liabilities / Total Assets	30.67	25.5	30.17	27.71	24.65
EBIT / Interest Expense	196.22	118.94	26.71	80.53	77.41
EBITDA / Interest Expense	315.26	247.3	66.66	137.46	130.27
(EBITDA - Capex) / Interest Expense	237.79	139.12	30.4	59.55	85.07
Total Debt / EBITDA	0.12	0.09	0.35	0.25	0.18
Net Debt / EBITDA	-1.48	-1.24	-1.74	-1.08	-1.25
Total Debt / (EBITDA - Capex)	0.16	0.16	0.77	0.57	0.27
Net Debt / (EBITDA - Capex)	-1.96	-2.2	-3.82	-2.49	-1.91
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.87	10.81	-2.91	14.35	1.08
Gross Profit, 1 Yr. Growth %	11.86	-3.01	-2.8	30.02	2.03
EBITDA, 1 Yr. Growth %	17.55	-17.28	-7.52	58.02	0.98
EBITA, 1 Yr. Growth %	23.05	-29.22	-16.24	98.07	1.77
EBIT, 1 Yr. Growth %	26.73	-36.08	-22.96	131.08	2.42
Earnings From Cont. Operations, 1 Yr. Growth %	46.62	-31.06	-54.26	175.48	19.91
Net Income, 1 Yr. Growth %	45.88	-30.82	-54.46	176.1	20.02
Normalized Net Income, 1 Yr. Growth %	33.99	-30.76	-26.18	122.79	-0.37
Diluted EPS Before Extra, 1 Yr. Growth %	47.1	-27.69	-54.32	176.51	24.77
Accounts Receivable, 1 Yr. Growth %	-3.56	-5.85	10.12	-0.07	7.19
Inventory, 1 Yr. Growth %	36.7	28.01	-11.45	7.57	-8.4
Net Property, Plant and Equip., 1 Yr. Growth %	13.05	12.6	12.34	2.46	0.49
Total Assets, 1 Yr. Growth %	7.96	0.77	9.43	2.05	0.66
Tangible Book Value, 1 Yr. Growth %	7.04	9.58	2.52	7.69	7.38
Common Equity, 1 Yr. Growth %	6.27	8.18	2.58	5.63	4.94
Cash From Operations, 1 Yr. Growth %	-14.51	-75.91	560.46	-14	-0.79
Capital Expenditures, 1 Yr. Growth %	-5.28	47.25	15	64.65	-38.18
Levered Free Cash Flow, 1 Yr. Growth %	-51.63	-219.71	-341.06	-108.66	-825.22
Unlevered Free Cash Flow, 1 Yr. Growth %	-51.5	-217.87	-345.33	-107.78	-908.99
Dividend Per Share, 1 Yr. Growth %	12.82	0	0	13.64	10
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.29	9.84	3.72	5.37	7.51
Gross Profit, 2 Yr. CAGR %	5.57	4.16	-2.9	12.42	15.18
EBITDA, 2 Yr. CAGR %	10.9	-1.39	-12.53	20.89	26.32
EBITA, 2 Yr. CAGR %	15.11	-6.67	-23	28.81	41.98
EBIT, 2 Yr. CAGR %	18.23	-9.99	-29.83	33.43	53.84
Earnings From Cont. Operations, 2 Yr. CAGR %	32.01	0.54	-43.84	12.26	81.75
Net Income, 2 Yr. CAGR %	31.52	0.46	-43.87	12.14	82.04
Normalized Net Income, 2 Yr. CAGR %	21.95	-3.68	-28.51	28.24	48.99
Diluted EPS Before Extra, 2 Yr. CAGR %	32.04	3.14	-42.52	12.39	85.74
Accounts Receivable, 2 Yr. CAGR %	-0.42	-4.71	1.82	4.9	3.49
Inventory, 2 Yr. CAGR %	13.99	32.28	6.46	-2.41	-0.74
Net Property, Plant and Equip., 2 Yr. CAGR %	5.88	12.83	12.47	7.28	1.47
Total Assets, 2 Yr. CAGR %	4.14	4.3	5.01	5.68	1.35
Tangible Book Value, 2 Yr. CAGR %	6.38	8.3	5.99	5.07	7.54
Common Equity, 2 Yr. CAGR %	4.45	7.23	5.35	4.1	5.28
Cash From Operations, 2 Yr. CAGR %	15.41	-54.62	26.13	138.32	-7.63
Capital Expenditures, 2 Yr. CAGR %	-17.24	18.1	30.13	37.6	0.89
Levered Free Cash Flow, 2 Yr. CAGR %	35.44	-23.91	69.88	-54.32	-20.77
Unlevered Free Cash Flow, 2 Yr. CAGR %	34.37	-24.39	70.05	-56.3	-20.65
Dividend Per Share, 2 Yr. CAGR %	6.22	6.22	0	6.6	11.8
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	0.78	5.74	5.41	7.15	3.92
Gross Profit, 3 Yr. CAGR %	2.06	2.63	1.79	7.02	8.84
EBITDA, 3 Yr. CAGR %	4.98	0.58	-3.48	6.53	13.85
EBITA, 3 Yr. CAGR %	5.22	-2.12	-9.98	5.5	19.08
EBIT, 3 Yr. CAGR %	6.28	-3.68	-14.54	4.4	22.17
Earnings From Cont. Operations, 3 Yr. CAGR %	8.89	6.31	-22.67	-4.58	14.75
Net Income, 3 Yr. CAGR %	8.75	6.17	-22.83	-4.54	14.71
Normalized Net Income, 3 Yr. CAGR %	6.81	0.98	-11.85	4.43	17.89
Diluted EPS Before Extra, 3 Yr. CAGR %	9.03	8.03	-21.38	-2.97	16.38
Accounts Receivable, 3 Yr. CAGR %	-3.54	-2.26	-0	1.19	5.66
Inventory, 3 Yr. CAGR %	8.87	18.48	15.72	6.83	-4.44
Net Property, Plant and Equip., 3 Yr. CAGR %	6.29	8.07	12.66	9.03	4.97
Total Assets, 3 Yr. CAGR %	1.39	3	5.98	4.01	3.98
Tangible Book Value, 3 Yr. CAGR %	5.63	7.43	6.34	6.55	5.84
Common Equity, 3 Yr. CAGR %	3.33	5.68	5.65	5.44	4.38
Cash From Operations, 3 Yr. CAGR %	2.54	-31.54	10.8	11.02	77.95
Capital Expenditures, 3 Yr. CAGR %	-7.5	0.28	17.06	40.75	5.39
Levered Free Cash Flow, 3 Yr. CAGR %	-6.21	29.98	11.76	-37.02	14.81
Unlevered Free Cash Flow, 3 Yr. CAGR %	-6.33	28.63	11.94	-39.17	15.6
Dividend Per Share, 3 Yr. CAGR %	4.1	4.1	4.1	4.35	7.72
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.51	2.71	1.95	5.59	6.25
Gross Profit, 5 Yr. CAGR %	4.27	0.11	0.04	6.44	6.95
EBITDA, 5 Yr. CAGR %	7.3	-2.5	-2.41	8.26	7.49
EBITA, 5 Yr. CAGR %	7.94	-5.7	-7.13	9.25	8.02
EBIT, 5 Yr. CAGR %	5.4	-7.25	-9.98	9.73	8.11
Earnings From Cont. Operations, 5 Yr. CAGR %	8.28	0.62	-16.45	8.65	8.84
Net Income, 5 Yr. CAGR %	7.76	0.45	-16.53	8.52	8.78
Normalized Net Income, 5 Yr. CAGR %	6.46	-3.68	-9.03	11.11	8.74
Diluted EPS Before Extra, 5 Yr. CAGR %	7.92	1.49	-15.6	9.75	10.89
Accounts Receivable, 5 Yr. CAGR %	-1.36	-4.15	-1.43	0.54	1.38
Inventory, 5 Yr. CAGR %	8.72	11.8	7.9	9.64	8.83
Net Property, Plant and Equip., 5 Yr. CAGR %	4.08	6.16	8.72	7.76	8.04
Total Assets, 5 Yr. CAGR %	1.99	0.82	2.82	4.06	4.11
Tangible Book Value, 5 Yr. CAGR %	6.43	6.35	5.77	6.48	6.81
Common Equity, 5 Yr. CAGR %	3.29	4.02	4.13	5.04	5.51
Cash From Operations, 5 Yr. CAGR %	0.23	-26.04	11.39	12.75	3.02
Capital Expenditures, 5 Yr. CAGR %	-8.17	9.19	6.03	13.81	10.3
Levered Free Cash Flow, 5 Yr. CAGR %	28.29	-11.52	18.95	-14.45	-2.61
Unlevered Free Cash Flow, 5 Yr. CAGR %	28.02	-11.78	18.91	-16.48	-2.45
Dividend Per Share, 5 Yr. CAGR %	5.92	5.92	2.44	5.09	7.12